Skip to main content

Advertisement

SpringerLink
Log in

Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience

  • Letter to the Editor - Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Patel AM, Moreland LW (2010) Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des Dev Ther 4:263–278

    Google Scholar 

  2. Dhillon S (2014) Intravenous tocilizumab: a review of its use in adults with rheumatoid arthritis. BioDrugs 28:75–106

    Article  CAS  PubMed  Google Scholar 

  3. Tanaka T, Hishitani Y, Ogata A (2014) Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors. Biologics 8:141–153

    PubMed Central  PubMed  Google Scholar 

  4. van Herwaarden N, Herfkens-Hol S, van der Maas A, van den Bemt BJ, van Vollenhoven RF, Bijlsma JW, den Broeder AA (2014) Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity. Clin Exp Rheumatol 32:390–394

    PubMed  Google Scholar 

  5. Epis O, Giacomelli L, Bruschi E (2013) Imaging in rheumatology: ultrasafe + ultrasure = ultrasound. Rheumatol Int 33:1901–1903

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Rheumatology Unit, Niguarda Ca’ Granda Hospital, Piazza Ospedale Maggiore 3, 20162, Milan, Italy

    Oscar Epis, Cinzia Casu, Laura Belloli, Emanuela Schito, Davide Filippini, Marina Muscarà & Eleonora Bruschi

Authors
  1. Oscar Epis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cinzia Casu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Belloli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emanuela Schito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Davide Filippini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marina Muscarà
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eleonora Bruschi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oscar Epis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Epis, O., Casu, C., Belloli, L. et al. Reduced dose of tocilizumab for the maintenance of remission in patients with rheumatoid arthritis: a clinical experience. Rheumatol Int 35, 1569–1570 (2015). https://doi.org/10.1007/s00296-015-3243-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3243-z

Keywords

Search

Navigation